28-4480
Sodium thiocyanate
JIS special grade, ≥99.0%
Synonym(s):
Sodium isothiocyanate, Sodium rhodanate, Sodium rhodanide, Sodium sulfocyanate
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Linear Formula:
NaSCN
CAS Number:
Molecular Weight:
81.07
EC Number:
208-754-4
UNSPSC Code:
12352300
PubChem Substance ID:
Beilstein/REAXYS Number:
3594965
MDL number:
Assay:
≥99.0%
Grade:
JIS special grade
Form:
crystalline
grade
JIS special grade
assay
≥99.0%
form
crystalline
availability
available only in Japan
pH
4.8 (20.1 °C, 1070 g/L)
mp
287 °C (dec.) (lit.)
SMILES string
[Na]SC#N
InChI
1S/CHNS.Na/c2-1-3;/h3H;/q;+1/p-1
InChI key
VGTPCRGMBIAPIM-UHFFFAOYSA-M
Still not finding the right product?
Explore all of our products under Sodium thiocyanate
signalword
Danger
Hazard Classifications
Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 3 - Eye Dam. 1
supp_hazards
Storage Class
13 - Non Combustible Solids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
dust mask type N95 (US), Eyeshields, Gloves
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Sandra Romero-Steiner et al.
Clinical and diagnostic laboratory immunology, 12(9), 1029-1035 (2005-09-09)
Determination of antibody avidity measurements can be difficult in human serum depending on the population evaluated. We evaluated three approaches for the determination of antibody avidity for immunoglobulin G (IgG). These approaches were (i) elution of bound antibody with increasing
Vincent Ball et al.
Langmuir : the ACS journal of surfaces and colloids, 21(9), 4129-4137 (2005-04-20)
In this study, we investigate the buildup of PEI-(PSS-PAH)(n) polyelectrolyte multilayers at pH 7.4 in the presence of either NaCl or NaSCN as a supporting electrolyte. It appears that in the presence of increasing thiocyanate concentrations (from 0.1 to 0.5
John W J Hinrichs et al.
American journal of clinical pathology, 143(4), 573-578 (2015-03-18)
To compare next-generation sequencing (NGS) platforms with mutation-specific analysis platforms in a clinical setting, in terms of sensitivity, mutation specificity, costs, capacity, and ease of use. We analyzed 25 formalin-fixed, paraffin-embedded lung cancer samples of different size and tumor percentage